Cargando…

Repeat kidney transplant recipients with active rejection have elevated donor‐derived cell‐free DNA

Detalles Bibliográficos
Autores principales:	Mehta, Shikha G., Chang, Jae H., Alhamad, Tarek, Bromberg, Jonathan S., Hiller, David J., Grskovic, Marica, Yee, James P., Mannon, Roslyn B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587949/ https://www.ncbi.nlm.nih.gov/pubmed/30468563 http://dx.doi.org/10.1111/ajt.15192

Ejemplares similares

Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients
por: Jordan, Stanley C., et al.
Publicado: (2018)

Observed elevated donor‐derived cell free DNA in orthotopic heart transplant recipients without clinical evidence of rejection
por: Afzal, Aasim, et al.
Publicado: (2021)

Sociodemographic Drivers of Donor and Recipient Gender Disparities in Living Kidney Donation in Australia
por: Kim, Siah, et al.
Publicado: (2023)

Efficacy and Safety of Tocilizumab in the Treatment of Acute Active Antibody-mediated Rejection in Kidney Transplant Recipients
por: Pottebaum, April A., et al.
Publicado: (2020)

Endothelial failure and rejection in recipients of corneas from the same donor
por: Downward, Lewis, et al.
Publicado: (2022)

Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design
por: Nickerson, Peter W., et al.
Publicado: (2022)

THE EFFECT OF SKIN HOMOGRAFT REJECTION ON RECIPIENT AND DONOR MIXED LEUKOCYTE CULTURES
por: Oppenheim, Joost J., et al.
Publicado: (1965)

Application of plasma donor-derived cell free DNA for lung allograft rejection diagnosis in lung transplant recipients
por: Ju, Chunrong, et al.
Publicado: (2023)

High levels of dd‐cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury
por: Stites, Erik, et al.
Publicado: (2020)

Diagnostic value of donor‐derived cell‐free DNA to predict antibody‐mediated rejection in donor‐specific antibody‐positive renal allograft recipients
por: Mayer, Katharina A., et al.
Publicado: (2021)

Preliminary clinical experience applying donor-derived cell-free DNA to discern rejection in pediatric liver transplant recipients
por: Zhao, Dong, et al.
Publicado: (2021)

Causes of Renal Allograft Injury in Recipients With Normal Donor-derived Cell-free DNA
por: Xie, Wen Yan, et al.
Publicado: (2021)

Donor plasma mitochondrial DNA is associated with antibody-mediated rejection in renal allograft recipients
por: Han, Fei, et al.
Publicado: (2021)

Donor-But Not Recipient-Derived Cells Produce Collagen-1 in Chronically Rejected Cardiac Allografts
por: Balam, Saidou, et al.
Publicado: (2022)

Emerging Therapies for Antibody-Mediated Rejection in Kidney Transplantation
por: Abuazzam, Farah, et al.
Publicado: (2023)

The Measurement of Donor-Specific Cell-Free DNA Identifies Recipients With Biopsy-Proven Acute Rejection Requiring Treatment After Liver Transplantation
por: Goh, Su Kah, et al.
Publicado: (2019)

Donor-derived Cell-free DNA in Infections in Kidney Transplant Recipients: Case Series
por: Goussous, Naeem, et al.
Publicado: (2020)

Detection of Donor-Derived Microparticles in the Peripheral Blood of a Hand Transplant Recipient During Rejection
por: Kim, Joseph Y., et al.
Publicado: (2017)

Donor-Derived Cell-Free DNA and Active Rejection in Renal Allografts
por: Fernando, Edwin, et al.
Publicado: (2023)

Donor-derived, cell-free DNA levels by next-generation targeted sequencing are elevated in allograft rejection after lung transplantation
por: Khush, Kiran K., et al.
Publicado: (2021)

Patterns in Use and Transplant Outcomes Among Adult Recipients of Kidneys From Deceased Donors With COVID-19
por: Ji, Mengmeng, et al.
Publicado: (2023)

Utility of Donor-Derived Cell-Free DNA in Detecting ABMR in Patients With AT1R Antibodies
por: Kant, Sam, et al.
Publicado: (2021)

Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection
Publicado: (1992)

Donor and recipient genetic variants in NLRP3 associate with early acute rejection following kidney transplantation
por: Dessing, Mark C., et al.
Publicado: (2016)

Is It Time for Operation Warp Speed in Transplant Research?
por: Mannon, Roslyn B.
Publicado: (2020)

Induced pluripotent stem cells in the study of neurological diseases
por: Saporta, Mario A, et al.
Publicado: (2011)

Hormone replacement therapy and COVID-19 outcomes in solid organ transplant recipients compared with the general population
por: Vinson, Amanda J., et al.
Publicado: (2023)

Rat Cytomegalovirus Vaccine Prevents Accelerated Chronic Rejection in CMV‐Naïve Recipients of Infected Donor Allograft Hearts
por: Streblow, D. N., et al.
Publicado: (2015)

Class and Kinetics of Weakly Reactive Pretransplant Donor-specific HLA Antibodies Predict Rejection in Kidney Transplant Recipients
por: Morrison, Alexander H., et al.
Publicado: (2019)

Clinical significance of de novo donor-specific antibody in kidney transplant recipients with chronic antibody-mediated rejection
por: Park, Woo Yeong, et al.
Publicado: (2021)

Low Incidence of Acute Antibody-Mediated Rejection after HLA Desensitization in Living Donor Kidney Transplant Recipients
por: Fernández Rivera, Constantino, et al.
Publicado: (2022)

Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study
por: Zhang, Huanxi, et al.
Publicado: (2020)

The Use of Donor-Derived Cell-Free DNA for Assessment of Allograft Rejection and Injury Status
por: Thongprayoon, Charat, et al.
Publicado: (2020)

Donor-Derived Cell-Free DNA for Acute Rejection Monitoring in Heart and Lung Transplantation
por: Keller, Michael, et al.
Publicado: (2021)

Financial Evaluation of Kidney Transplant With Hepatitis C Viremic Donors to Uninfected Recipients
por: Axelrod, David A., et al.
Publicado: (2020)

Alemtuzumab Induction and Delayed Acute Rejection in Steroid-Free Simultaneous Pancreas-Kidney Transplant Recipients
por: Bank, Jonna R., et al.
Publicado: (2016)

Utility of Serial Donor-derived Cell-free DNA Measurements for Detecting Allograft Rejection in a Kidney Transplant Recipient After PD-1 Checkpoint Inhibitor Administration
por: Lakhani, Laila, et al.
Publicado: (2021)

Specific suppression of allograft rejection by trinitrophenyl (TNP)- induced suppressor cells in recipients treated with TNP-haptenated donor alloantigens
Publicado: (1985)

An Algorithm Measuring Donor Cell-Free DNA in Plasma of Cellular and Solid Organ Transplant Recipients That Does Not Require Donor or Recipient Genotyping
por: Gordon, Paul M. K., et al.
Publicado: (2016)

From the Cradle to the Grave: The Life Cycle of Gender Disparities in Kidney Care
por: Lalji, Rowena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m75ou2gs0d077f0f573e17bt9g